Skip to main content Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NYSE: BSX

Boston Scientific Corporation

Healthcare | Medical - Devices
$56.91 -5.16 (-8.31%) as of 2026-07-14 17:17 UTC
Market Cap$85.0B
EPS (TTM)$1.94

Boston Scientific Corporation (NYSE: BSX) is a $85.0B medical - devices company trading at $56.91 (−8.3% today) — 29.3× trailing earnings. Figures from SEC EDGAR and market feeds; updated 2026-07-14 17:17 UTC.

52-Week Range
Low $56.51High $109.50

What Boston Scientific Corporation does

Boston Scientific Corporation is a medical device manufacturer that develops, manufactures and markets devices used across multiple medical specialties including cardiovascular, respiratory, digestive, oncological, neurological and urological conditions. The company operates through two reportable segments: MedSurg, which includes endoscopy, urology and neuromodulation businesses, and Cardiovascular, which focuses on interventional cardiology and vascular therapies.

Summarized from Boston Scientific Corporation’s SEC filings · Read the filing ↗

Key facts
Quote
Price$56.91
Change (1D)-5.16 (-8.31%)
Market cap$85.0B
52-week range$56.51 – $109.50
Valuation
P/E (TTM)29.34×
EV/EBITDA20.40×
EPS (TTM)$1.94
Price/book3.48×
Return on equity11.82%
Debt/equity0.01
Returns
52-week return+0.7%
Revenue, margins & earnings
FY2021 Net income: $1.04BFY2021 Taxes & interest: $158MFY2021 Operating expenses: $6.98BFY2021 Cost of revenue: $3.71B$11.9BFY2021FY2022 Net income: $698MFY2022 Taxes & interest: $951MFY2022 Operating expenses: $7.08BFY2022 Cost of revenue: $3.96B$12.7BFY2022FY2023 Net income: $1.59BFY2023 Taxes & interest: $751MFY2023 Operating expenses: $7.55BFY2023 Cost of revenue: $4.34B$14.2BFY2023FY2024 Net income: $1.85BFY2024 Taxes & interest: $757MFY2024 Operating expenses: $8.89BFY2024 Cost of revenue: $5.26B$16.7BFY2024FY2025 Net income: $2.89BFY2025 Taxes & interest: $721MFY2025 Operating expenses: $10.2BFY2025 Cost of revenue: $6.22B$20.1BFY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
Annual revenue; bands show net, operating, gross margins · Open in Platform →
SEC Filings SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-07-02
  • 2026-07-02Monson JonathanEVP and CFOF-1,010$43.5K
  • 2026-07-02Monson JonathanEVP and CFOM2,087—
  • 2026-07-02Monson JonathanEVP and CFOM-2,087—
Sign in to see all transactions →
Top Institutional Holders (latest 13F)
Source: SEC EDGAR · As of 2026-Q1
  • VANGUARD GROUP INC139,685,720$13.32B+1.0%
  • BlackRock, Inc.127,655,311$8.01B-6.1%
  • VANGUARD CAPITAL MANAGEMENT LLC96,411,568$6.05BNEW
View QoQ ownership changes →
Company news View all →
Questions this page answers

What does Boston Scientific Corporation do?

Boston Scientific Corporation is a medical device manufacturer that develops, manufactures and markets devices used across multiple medical specialties including cardiovascular, respiratory, digestive, oncological, neurological and urological conditions.

What is BSX's valuation?

BSX trades at $56.91, 29.34× trailing earnings, 20.40× EV/EBITDA, as of 2026-07-14.

When did BSX last file with the SEC?

Boston Scientific Corporation's most recent SEC filing on record is a 8-K filed 2026-05-18. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings and public market data feeds, fetched 2026-07-14 17:17 UTC. This page is also available as JSON at /api/data?ticker=BSX and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for BSX and 3,500+ tickers.

Create a free account — keep BSX
For your agent
GET /api/data?ticker=BSX

This page as JSON via rel="alternate" · REST API docs · MCP server (51 tools) · llms.txt